Chemoprevention of breast cancer with selective oestrogen-receptor modulators

Twenty years ago, a new therapeutic dimension was conceived that not only had the potential to treat and prevent osteoporosis, but to prevent breast and endometrial cancer at the same time. As osteoporosis was known to be caused by oestrogen withdrawal after menopause, whereas breast and endometrial...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature reviews. Cancer 2007-01, Vol.7 (1), p.46-53
1. Verfasser:	Jordan, V. Craig
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticarcinogenic Agents - pharmacology Breast cancer Breast Neoplasms - prevention & control Chemoprevention Chemoprevention - methods Drug therapy Endometrial Neoplasms - prevention & control Female Health aspects Humans Methods Models, Biological Models, Chemical Raloxifene Hydrochloride - pharmacology Receptors, Estrogen - metabolism Risk factors Selective Estrogen Receptor Modulators - pharmacology Tamoxifen - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!